[go: up one dir, main page]

(Q42996968)

English

Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection

scientific article published on 16 November 2005

In more languages
default for all languages
No label defined

No description defined

Statements

Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection (English)
Shinn-Cherng Chen

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit